Metastatic melanoma
Showing 1 - 25 of >10,000
Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)
Active, not recruiting
- Tumor Skin
- +2 more
- OBX-115
-
Orlando, Florida
- +1 more
Sep 28, 2023
Healthcare Resource Utilization and Costs in Metastatic Melanoma
Terminated
- Metastatic Melanoma
-
East Hanover, New JerseyNovartis Investigational Site
Apr 27, 2023
Baseline Metastases on Clinical Outcomes Among BRAF Positive
Completed
- BRAF Positive Metastatic Melanoma
-
East Hanover, New JerseyNovartis
Aug 2, 2023
Immunotherapy in Patients With Metastatic Melanoma
Not yet recruiting
- Metastatic Melanoma
- data collection
- (no location specified)
Nov 28, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Rigosertib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 28, 2023
Associated Factors, and Clinical Outcomes of Prescribing
Completed
- BRAF v600 Mutated Metastatic Melanoma
-
East Hanover, New JerseyNovartis Pharmaceuticals
Mar 28, 2023
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)
Not yet recruiting
- Metastatic Melanoma
- Head and Neck Squamous Cell Carcinoma
- GB1211
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 19, 2023
Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)
Not yet recruiting
- Advanced Melanoma
- Metastatic Melanoma
- Memory-like natural killer cells
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 16, 2022
Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)
Recruiting
- Unresectable Melanoma
- Metastatic Melanoma
- NEO-PTC-01
-
Brussel, Belgium
- +2 more
Dec 5, 2022
Metastatic Melanoma Trial in Marseille (PET with 18F-FDOPA)
Completed
- Metastatic Melanoma
- PET with 18F-FDOPA
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Nov 9, 2022
Metastatic Melanoma Trial in Tampa (procedure, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Surgery
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Immunotherapy Among BRAF-Positive Melanoma Patients Treated in
Completed
- Metastatic Melanoma
- Nivolumab
- +5 more
-
East Hanover, New JerseyNovartis Investigative Site
Nov 11, 2022
Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover
Not yet recruiting
- Metastatic Melanoma
- +2 more
- Lifileucel plus Pembrolizumab
- Pembrolizumab with Optional Crossover Period
- (no location specified)
Feb 13, 2023
Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)
Completed
- Metastatic Melanoma
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 31, 2022
Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute
Recruiting
- Metastatic Melanoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Aerosol Sargramostim
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Tumor, Metastatic Melanoma, Melanoma Trial in Houston (OBX-115, Acetazolamide, Cyclophosphamide)
Not yet recruiting
- Tumor
- +2 more
- OBX-115
- +5 more
-
Houston, TexasMD Anderson Cancer Center
Aug 16, 2022
Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))
Recruiting
- Uveal Melanoma
- +3 more
- Lifileucel (LN-144)
-
Harrison, New York
- +1 more
Nov 8, 2022